Please assess the completion status of the following clinical trial:

Trial Title: Extracellular Fluid in Resistant Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* BP \>140/85~* 3 antihypertensive drugs (ACE/ARB + calcium channel blocker + thiazide diuretic)~Exclusion Criteria:~* Pregnancy~* Breast Feeding~* Unstable heart failure~* Chronic Liver Disease~* Creatinine \>120 mcmol/L~* Contraindication to (or intolerance of) drug used in study~* BP \> 180/110

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).